Overview
The actively managed fund predominantly invests in CHF-denominated bonds from foreign issuers with high creditworthiness (classified as investment grade by the established rating agencies).
The fund may also invest opportunistically in non-denominated CHF bonds, emerging market and high yield bonds. The portfolio has an average credit quality of investment grade.
The fund takes active positions in interest rates, credit and currencies using bonds and derivatives.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
Clients have access to a diversified CHF bond portfolio offering attractive return potential.
The fund strives to achieve a better return over the medium term compared to the CHF foreign bond market.
The fund manager combines a mix of carefully selected issuers and bonds across a range of maturities with the aim of exploiting return opportunities.
The portfolio is subject to strict risk management processes.
Risks
Features
| Product category |
麻豆社 Bond Funds 麻豆社 Classic Bond Funds |
| Product domicile |
Luxembourg
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Asset Management (Europe) S.A., Luxembourg
|
| Custodian bank |
麻豆社 Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
麻豆社 Asset Management (UK) Limited
|
| Day of inception |
02 October 2015
|
| Currency of account |
CHF
|
| Close of financial year |
31 March
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.54% p.a.
|
| Management fee |
0.37% p.a.
|
| Total expense ratio (TER) |
0.54% p.a.
|
| Swing pricing |
yes
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SBI® Foreign AAA-BBB (TR)
|
| ISIN |
LU0415163640
|
| Bloomberg Ticker |
麻豆社CHQD LX
|
Performance and Prices
Percentage growth
as of 18 June 2026| CHF(%) | EUR(%) | |
| YTD | ||
| 1M | ||
| 3M | 0.60 | -0.80 |
| 6M | 0.75 | 1.81 |
| 1Y | 0.77 | 2.94 |
| 2Y | 5.79 | 9.06 |
| 3Y | 11.67 | 18.37 |
| 5Y | ||
| ø p.a.5Y | 0.29 | 3.79 |
| CHF(%) | EUR(%) | |
| Q1 2025 to Q1 2026 | 1.02 | 4.28 |
| Q1 2024 to Q1 2025 | 4.17 | 6.03 |
| Q1 2023 to Q1 2024 | 6.66 | 8.83 |
| Q1 2022 to Q1 2023 | -1.98 | 1.12 |
| Q1 2021 to Q1 2022 | -8.23 | -0.86 |
Current data
| Net asset value | 18.06.2026 | CHF 97.47 |
| High - last 12 months | 27.02.2026 | CHF 98.87 |
| Low - last 12 months | 08.06.2026 | CHF 96.86 |
| Last distribution | 04.06.2026 | CHF 0.95 |
| Assets of the unit class in mn | 17.06.2026 | CHF 6.75 |
| Total product assets in mn | 17.06.2026 | CHF 425.13 |
| Average remaining maturity | 29.05.2026 | 7.41 years |
Structures
By the 10 largest positions (in %, as of 29 May 2026)
|
|
|
| Muenchener Hypothekenbank eG | 2.77 |
| BNP Paribas SA | 2.74 |
| Thermo Fisher Scientific Inc | 2.60 |
| Credit Agricole SA | 2.54 |
| Banco Santander SA | 2.39 |
| Landesbank Baden-Wuerttemberg | 2.07 |
| BPCE SA | 1.98 |
| New York Life Global Funding | 1.90 |
| Hypo Vorarlberg Bank AG | 1.86 |
| Deutsche Bahn AG | 1.84 |
Fees
Distributions
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Distribution
|
|
| 01.06.2026 | 04.06.2026 | 11 | CHF | 0.95 |
Sales Authorisations
Literature
|
Document type
|
Document Language
|
| Prospectus |
|
| Country supplement |
|
| Key Investor Information (KIID) |
|
| Past performance |
|
| Previous performance scenario |
|
|
Document type
|
Document Language
|
| Annual report |
|
| Semi-annual report |
|